# Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

> **NCT01658826** · PHASE2 · TERMINATED · sponsor: **AiCuris Anti-infective Cures AG** · enrollment: 91 (actual)

## Conditions studied

- Genital Herpes

## Interventions

- **DRUG:** AIC316
- **DRUG:** Valacyclovir

## Key facts

- **NCT ID:** NCT01658826
- **Lead sponsor:** AiCuris Anti-infective Cures AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2013-05
- **Final completion:** 2013-07
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2023-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01658826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01658826, "Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01658826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*